China SXT Pharmaceuticals (SXTC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.06, -5.80% vs the prior close of $0.07.
- Volume 260.86M shares, 20.7x its 50-day average (heavy).
- New SEC filings: SCHEDULE 13G (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
SXTC slides 5.8% to $0.06, a 52-week low on 20.7x normal volume. Closed at $0.06, -5.80% vs the prior close of $0.07. Day range $0.06–$0.08, opened at $0.08.
SXTC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — SXTC slides 5.8% to $0.06, a 52-week low on 20.7x normal volume
- Closed at $0.06, -5.80% vs the prior close of $0.07. Day range $0.06–$0.08, opened at $0.08.
- Volume was 260.86M shares, 20.7x its 50-day average of 12.63M — unusually heavy trading.
- Price is -97.4% vs its 50-day average ($2.52) and -100.0% vs its 200-day average ($786.58).
- 52-week range $0.06–$83,760.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
- That makes 7 straight losses.
Oct 15, 2026 — SXTC ends flat (+0.0%) to $0.07 on 5.2x normal volume
- Closed at $0.07, +0.00% vs the prior close of $0.07. Day range $0.06–$0.07, opened at $0.06.
- Volume was 59.02M shares, 5.2x its 50-day average of 11.42M — unusually heavy trading.
- Price is -97.4% vs its 50-day average ($2.61) and -100.0% vs its 200-day average ($871.18).
- 52-week range $0.06–$83,760.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
- That makes 6 straight losses.
Oct 14, 2026 — SXTC slides 10.4% to $0.07, a 52-week low on 3.1x normal volume
- Closed at $0.07, -10.39% vs the prior close of $0.08. Day range $0.06–$0.07, opened at $0.07.
- Volume was 33.51M shares, 3.1x its 50-day average of 10.79M — unusually heavy trading.
- Price is -97.5% vs its 50-day average ($2.71) and -100.0% vs its 200-day average ($959.38).
- 52-week range $0.06–$83,760.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — SXTC slides 24.5% to $0.08, a 52-week low on 6.1x normal volume
- Closed at $0.08, -24.51% vs the prior close of $0.10. Day range $0.07–$0.08, opened at $0.08.
- Volume was 59.63M shares, 6.1x its 50-day average of 9.71M — unusually heavy trading.
- Price is -97.4% vs its 50-day average ($2.91) and -100.0% vs its 200-day average ($1,049.98).
- 52-week range $0.07–$83,760.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — SXTC slides 31.5% to $0.10, a 52-week low on 10.2x normal volume
- Closed at $0.10, -31.54% vs the prior close of $0.15. Day range $0.09–$0.11, opened at $0.10.
- Volume was 82.69M shares, 10.2x its 50-day average of 8.07M — unusually heavy trading.
- Price is -96.6% vs its 50-day average ($3.03) and -100.0% vs its 200-day average ($1,141.84).
- 52-week range $0.09–$83,760.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — SXTC slides 56.7% to $0.15, a 52-week low on 19.8x normal volume
- Closed at $0.15, -56.69% vs the prior close of $0.34. Day range $0.12–$0.24, opened at $0.24.
- Volume was 116.28M shares, 19.8x its 50-day average of 5.88M — unusually heavy trading.
- Price is -95.2% vs its 50-day average ($3.13) and -100.0% vs its 200-day average ($1,234.24).
- 52-week range $0.12–$83,760.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
- SEC filings that day: 6-K, 424B5.
Oct 8, 2026 — SXTC slides 87.8% to $0.34, a 52-week low on 14.1x normal volume
- Closed at $0.34, -87.84% vs the prior close of $2.83. Day range $0.31–$0.46, opened at $0.46.
- Volume was 64.91M shares, 14.1x its 50-day average of 4.59M — unusually heavy trading.
- Price is -89.4% vs its 50-day average ($3.24) and -100.0% vs its 200-day average ($1,327.24).
- 52-week range $0.31–$83,760.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
- SEC filings that day: 6-K, 6-K.
Oct 7, 2026 — SXTC jumps 126.4% to $2.83 on 87.3x normal volume
- Closed at $2.83, +126.40% vs the prior close of $1.25. Day range $1.87–$9.59, opened at $3.19.
- Volume was 146.57M shares, 87.3x its 50-day average of 1.68M — unusually heavy trading.
- Price is -14.7% vs its 50-day average ($3.32) and -99.8% vs its 200-day average ($1,423.84).
- 52-week range $1.18–$83,760.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
Oct 6, 2026 — SXTC slides 39.9% to $1.25, a 52-week low on 6.1x normal volume
- Closed at $1.25, -39.90% vs the prior close of $2.08. Day range $1.18–$2.06, opened at $2.04.
- Volume was 9.55M shares, 6.1x its 50-day average of 1.57M — unusually heavy trading.
- Price is -62.7% vs its 50-day average ($3.35) and -99.9% vs its 200-day average ($1,516.23).
- 52-week range $1.18–$83,760.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — SXTC slides 13.7% to $2.08, 3 down days in a row
- Closed at $2.08, -13.69% vs the prior close of $2.41. Day range $1.54–$2.44, opened at $2.31.
- Volume was 949.00K shares, 0.6x its 50-day average of 1.63M — lighter than usual.
- Price is -39.6% vs its 50-day average ($3.44) and -99.9% vs its 200-day average ($1,610.42).
- 52-week range $1.54–$83,760.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — SXTC slides 18.6% to $2.41
- Closed at $2.41, -18.58% vs the prior close of $2.96. Day range $1.94–$3.09, opened at $3.00.
- Volume was 779.10K shares, 0.5x its 50-day average of 1.64M — lighter than usual.
- Price is -31.2% vs its 50-day average ($3.50) and -99.9% vs its 200-day average ($1,708.81).
- 52-week range $1.78–$83,760.00; today's close sits at 0% of that range, 100.0% below the 52-week high.
SXTC latest news & SEC filings
Every SEC filing by or about SXTC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 9, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 9, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 16, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 28, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 24, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 7, 2026 · Form F-3 — F-3 filing
F-3 filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 1, 2026 · Form 20-F — Annual report from a foreign company (20-F)
Annual report from a foreign company (20-F)
Fiscal year ended Mar 31, 2026:
- Net income: -$6.21M (prior year -$3.30M) (loss widened vs Mar 31, 2025)
- Diluted EPS: -$9.13 (prior year -$348.17) (loss narrowed vs Mar 31, 2025)
Things to know before you trade SXTC
- How much it moves: over the last 20 sessions the average daily move was 22.31% (largest 126.4%). That is a volatile stock.
- Liquidity: about 41.99M shares (≈$2.73M) trade per day on average.
- 52-week position: $0.06 vs a range of $0.06–$83,760.00 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:80 on Aug 10, 2026, 1:150 on Feb 3, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 9, 2026; 6-K Oct 8, 2026; 6-K Oct 8, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
SXTC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.08 | 0.08 | 0.06 | 0.06 | 260.86M |
| Oct 15, 2026 | 0.06 | 0.07 | 0.06 | 0.07 | 62.49M |
| Oct 14, 2026 | 0.07 | 0.07 | 0.06 | 0.07 | 33.51M |
| Oct 13, 2026 | 0.08 | 0.08 | 0.07 | 0.08 | 59.63M |
| Oct 12, 2026 | 0.10 | 0.11 | 0.09 | 0.10 | 82.69M |
| Oct 9, 2026 | 0.24 | 0.24 | 0.12 | 0.15 | 116.28M |
| Oct 8, 2026 | 0.46 | 0.46 | 0.31 | 0.34 | 64.91M |
| Oct 7, 2026 | 3.19 | 9.59 | 1.87 | 2.83 | 146.57M |
| Oct 6, 2026 | 2.04 | 2.06 | 1.18 | 1.25 | 9.55M |
| Oct 5, 2026 | 2.31 | 2.44 | 1.54 | 2.08 | 949.00K |
| Oct 2, 2026 | 3.00 | 3.09 | 1.94 | 2.41 | 779.10K |
| Oct 1, 2026 | 3.02 | 3.27 | 2.91 | 2.96 | 297.90K |
| Sep 30, 2026 | 2.79 | 3.10 | 2.76 | 3.01 | 186.20K |
| Sep 29, 2026 | 2.49 | 3.05 | 2.23 | 2.81 | 868.00K |
| Sep 28, 2026 | 2.59 | 2.74 | 2.52 | 2.52 | 41.70K |
| Sep 25, 2026 | 2.48 | 2.60 | 2.48 | 2.57 | 17.50K |
| Sep 24, 2026 | 2.53 | 2.60 | 2.48 | 2.55 | 40.10K |
| Sep 23, 2026 | 2.47 | 2.68 | 2.35 | 2.51 | 70.10K |
| Sep 22, 2026 | 2.31 | 2.49 | 2.30 | 2.47 | 64.00K |
| Sep 21, 2026 | 2.35 | 2.41 | 2.25 | 2.38 | 59.70K |
About China SXT Pharmaceuticals
China SXT Pharmaceuticals (SXTC) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in TAIZHOU. State of incorporation: Virgin Islands, British. Fiscal year ends March 31. SEC CIK 1723980.
SXTC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Yong Lip Chee | Director | Apr 27, 2026 |
| Xiaodong Ji | Director | Apr 27, 2026 |
| Tong Tony Liu | Director | Apr 27, 2026 |
| Jun Zheng | Director | Apr 27, 2026 |
| Feng Felix Zhou | Co-CEO and Director | Apr 27, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Xiaodong Sean Pan | Chief Financial Officer | Apr 27, 2026 |
| Lim Sze Beng Simon | Co-Chief Executive Officer | Apr 27, 2026 |
| Feng Felix Zhou | Co-CEO and Director | Apr 27, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
SXTC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
SXTC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on SXTC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.